Insider Trading activities of Vertex Pharmaceuticals Inc / Ma insiders. , Part 7

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vertex Pharmaceuticals Inc / Ma since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vertex Pharmaceuticals Inc / Ma since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Vertex Pharmaceuticals Inc / Ma since 2005. The reporting company's ticker symbol is VRTX. The reporting company's CIK number is 875320.
The total value of stock buying since 2005 is $3,407,145.
The total value of stock sales since 2005 is $809,886,607.
The total value of stock option exercises since 2005 is $276,914,777.



Table 2. Detailed insider stock purchases, sales, and option exercises of Vertex Pharmaceuticals Inc / Ma insiders (VRTX) , Part 7
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-05-09 Boger Joshua S (Director) Sale 3,314 60.95 201,988
2012-05-09 Boger Joshua S (Director) Option Ex 3,314 15.87 52,593
2012-05-09 Ullian Elaine (Director) Sale 20,000 60.58 1,211,600
2012-05-09 Ullian Elaine (Director) Option Ex 20,000 28.40 568,000
2012-05-08 Wysenski Nancy (EVP, Chief Commercial Officer) Sale 38,009 61.60 2,341,240
2012-05-08 Wysenski Nancy (EVP, Chief Commercial Officer) Option Ex 38,009 37.44 1,423,056
2012-05-07 Sachdev Amit (SVP, Corp Affairs & Pub Policy) Sale 58,750 52.13 3,062,637
2012-05-07 Sachdev Amit (SVP, Corp Affairs & Pub Policy) Option Ex 56,250 29.25 1,645,312
2012-05-07 Kelly Lisa (SVP, Human Resources) Sale 37,726 54.88 2,070,289
2012-05-07 Kelly Lisa (SVP, Human Resources) Option Ex 32,406 32.16 1,042,176
2012-05-07 Wysenski Nancy (EVP, Chief Commercial Officer) Sale 147,695 54.50 8,049,377
2012-05-07 Wysenski Nancy (EVP, Chief Commercial Officer) Option Ex 142,695 38.01 5,423,123
2012-05-07 Mueller Peter (EVP, Global R&D, CSO) Sale 79,500 53.56 4,258,417
2012-05-07 Mueller Peter (EVP, Global R&D, CSO) Option Ex 79,500 15.51 1,232,806
2012-05-02 Boger Joshua S (Director) Sale 4,000 38.39 153,560
2012-05-02 Boger Joshua S (Director) Option Ex 4,000 15.87 63,480
2012-04-25 Boger Joshua S (Director) Sale 4,000 37.72 150,880
2012-04-25 Boger Joshua S (Director) Option Ex 4,000 15.87 63,480
2012-04-23 Boger Joshua S (Director) Sale 65 35.82 2,328
2012-04-18 Boger Joshua S (Director) Sale 4,000 35.88 143,520
2012-04-18 Boger Joshua S (Director) Option Ex 4,000 15.87 63,480
2012-04-11 Boger Joshua S (Director) Sale 4,000 37.23 148,920
2012-04-11 Boger Joshua S (Director) Option Ex 4,000 15.87 63,480
2012-04-04 Boger Joshua S (Director) Sale 4,000 41.03 164,120
2012-04-04 Boger Joshua S (Director) Option Ex 4,000 15.87 63,480
2012-03-30 Sachdev Amit (SVP, Corp Affairs & Pub Policy) Sale 26,562 41.01 1,089,307
2012-03-30 Sachdev Amit (SVP, Corp Affairs & Pub Policy) Option Ex 19,062 18.93 360,843
2012-03-28 Boger Joshua S (Director) Sale 4,000 40.88 163,540
2012-03-28 Boger Joshua S (Director) Option Ex 4,000 15.87 63,480
2012-02-29 Silva Paul M (SVP & Corp Controller) Sale 6,875 39.36 270,600
2012-02-08 Sachdev Amit (SVP, Corp Affairs & Pub Policy) Sale 4,066 36.81 149,669
2012-02-08 Kelly Lisa (SVP, Human Resources) Sale 8,133 36.80 299,294
2012-02-08 Smith Ian F (EVP & CFO) Sale 9,667 36.80 355,745
2012-01-19 Sachdev Amit (SVP, Corp Affairs & Pub Policy) Sale 4,066 37.00 150,442
2012-01-19 Kelly Lisa (SVP, Human Resources) Sale 10,166 37.00 376,142
2012-01-19 Wysenski Nancy (EVP, Chief Commercial Officer) Sale 6,042 37.00 223,554
2012-01-19 Smith Ian F (EVP & CFO) Sale 6,042 37.00 223,554
2011-12-12 Wysenski Nancy (EVP, Chief Commercial Officer) Sale 5,000 28.90 144,500
2011-12-06 Boger Joshua S (Director) Option Ex 4,054 24.66 99,971
2011-12-01 Boger Joshua S (Director) Sale 4,946 29.23 144,571
2011-12-01 Boger Joshua S (Director) Option Ex 4,946 24.66 121,968
2011-11-23 Boger Joshua S (Director) Sale 4,000 27.17 108,680
2011-11-23 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-11-16 Boger Joshua S (Director) Sale 4,000 29.71 118,840
2011-11-16 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-11-15 Silva Paul M (SVP & Corp Controller) Sale 27 29.74 802
2011-11-15 Wysenski Nancy (EVP, Chief Commercial Officer) Sale 606 29.77 18,040
2011-11-15 Smith Ian F (EVP & CFO) Sale 20 29.75 595
2011-11-09 Boger Joshua S (Director) Sale 4,000 30.89 123,580
2011-11-09 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-11-02 Boger Joshua S (Director) Sale 4,000 37.42 149,680
2011-11-02 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-10-26 Boger Joshua S (Director) Sale 4,000 42.05 168,212
2011-10-26 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-10-19 Boger Joshua S (Director) Sale 4,000 40.84 163,360
2011-10-19 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-10-11 Boger Joshua S (Director) Sale 4,000 40.04 160,160
2011-10-11 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-10-05 Boger Joshua S (Director) Sale 4,000 44.06 176,240
2011-10-05 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-09-28 Boger Joshua S (Director) Sale 4,000 46.65 186,600
2011-09-28 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-09-21 Boger Joshua S (Director) Sale 4,000 53.05 212,180
2011-09-21 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-09-20 Mueller Peter (EVP, Global R&D, CSO) Sale 25,000 52.50 1,312,500
2011-09-20 Mueller Peter (EVP, Global R&D, CSO) Option Ex 25,000 18.05 451,125
2011-09-15 Mueller Peter (EVP, Global R&D, CSO) Sale 9,500 50.23 477,137
2011-09-15 Mueller Peter (EVP, Global R&D, CSO) Option Ex 9,500 11.27 107,065
2011-09-14 Boger Joshua S (Director) Sale 4,000 50.27 201,060
2011-09-14 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-09-13 Boger Kenneth S (SVP & Chief Legal Officer) Sale 22,000 50.00 1,100,000
2011-09-13 Boger Kenneth S (SVP & Chief Legal Officer) Option Ex 22,000 18.75 412,500
2011-09-08 Kelly Lisa (SVP, Human Resources) Sale 953 47.50 45,267
2011-09-08 Kelly Lisa (SVP, Human Resources) Option Ex 953 18.93 18,040
2011-09-07 Boger Joshua S (Director) Sale 4,000 46.48 185,920
2011-09-07 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-09-01 Howton David T (SVP) Sale 328 44.29 14,527
2011-08-31 Kelly Lisa (SVP, Human Resources) Sale 2,327 45.90 106,809
2011-08-31 Kelly Lisa (SVP, Human Resources) Option Ex 953 18.93 18,040
2011-08-31 Boger Joshua S (Director) Sale 4,000 45.93 183,720
2011-08-31 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-08-29 Mueller Peter (EVP, Global R&D, CSO) Sale 9,500 45.01 427,595
2011-08-29 Mueller Peter (EVP, Global R&D, CSO) Option Ex 9,500 10.84 102,980
2011-08-24 Boger Joshua S (Director) Sale 4,000 46.01 184,020
2011-08-24 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-08-17 Boger Joshua S (Director) Sale 4,000 46.51 186,040
2011-08-17 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-08-10 Boger Joshua S (Director) Sale 4,000 42.92 171,700
2011-08-10 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-08-03 Boger Joshua S (Director) Sale 4,000 47.99 191,948
2011-08-03 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-07-27 Boger Joshua S (Director) Sale 4,000 48.09 192,380
2011-07-27 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-07-25 Sachdev Amit (SVP, Corp Affairs & Pub Policy) Sale 1,500 49.94 74,910
2011-07-20 Boger Joshua S (Director) Sale 4,000 49.90 199,600
2011-07-20 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-07-20 Boger Kenneth S (SVP & General Counsel) Sale 7,333 50.04 366,943
2011-07-20 Boger Kenneth S (SVP & General Counsel) Option Ex 7,333 18.75 137,493
2011-07-15 Mueller Peter (EVP, Global R&D, CSO) Sale 2,500 50.68 126,700
2011-07-15 Mueller Peter (EVP, Global R&D, CSO) Option Ex 2,500 10.41 26,025
2011-07-13 Boger Joshua S (Director) Sale 4,000 51.87 207,480
2011-07-13 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-07-13 Boger Kenneth S (SVP & General Counsel) Sale 7,334 51.92 380,781
2011-07-13 Boger Kenneth S (SVP & General Counsel) Option Ex 7,334 18.75 137,512
2011-07-12 Kelly Lisa (SVP, Human Resources) Sale 953 51.22 48,812
2011-07-12 Kelly Lisa (SVP, Human Resources) Option Ex 953 28.84 27,484
2011-07-06 Boger Joshua S (Director) Sale 4,000 50.28 201,120
2011-07-06 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-07-06 Boger Kenneth S (SVP & General Counsel) Sale 7,333 51.01 374,056
2011-07-06 Boger Kenneth S (SVP & General Counsel) Option Ex 7,333 18.75 137,493
2011-06-29 Boger Joshua S (Director) Sale 4,000 51.26 205,040
2011-06-29 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-06-29 Boger Kenneth S (SVP & General Counsel) Sale 7,334 51.13 375,024
2011-06-29 Boger Kenneth S (SVP & General Counsel) Option Ex 7,334 18.75 137,512
2011-06-28 Boger Kenneth S (SVP & General Counsel) Sale 14,667 50.00 733,350
2011-06-28 Boger Kenneth S (SVP & General Counsel) Option Ex 14,667 18.75 275,006
2011-06-22 Boger Joshua S (Director) Sale 4,000 46.81 187,240
2011-06-22 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-06-15 Mueller Peter (EVP, Global R&D, CSO) Sale 2,500 46.82 117,050
2011-06-15 Mueller Peter (EVP, Global R&D, CSO) Option Ex 2,500 10.41 26,025
2011-06-15 Boger Joshua S (Director) Sale 4,000 46.66 186,640
2011-06-15 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-06-08 Boger Joshua S (Director) Sale 4,000 53.32 213,280
2011-06-08 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-06-08 Boger Kenneth S (SVP & General Counsel) Sale 7,333 53.38 391,435
2011-06-08 Boger Kenneth S (SVP & General Counsel) Option Ex 7,333 18.75 137,493
2011-06-03 Sachs Bruce I (Director) Sale 7,500 55.02 412,650
2011-06-02 Boger Joshua S (Director) Sale 4,000 53.55 214,200
2011-06-01 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-06-01 Boger Kenneth S (SVP & General Counsel) Sale 7,334 53.87 395,045
2011-06-01 Boger Kenneth S (SVP & General Counsel) Option Ex 7,334 18.75 137,512
2011-05-27 Sachs Bruce I (Director) Option Ex 7,500 44.47 333,525
2011-05-25 Kelly Lisa (SVP, Human Resources) Sale 4,160 55.85 232,356
2011-05-25 Emmens Matthew (CEO & President) Sale 9,735 55.51 540,389
2011-05-25 Smith Ian F (EVP & CFO) Sale 12,084 55.87 675,072
2011-05-25 Boger Joshua S (Director) Sale 4,000 55.87 223,480
2011-05-25 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-05-25 Boger Kenneth S (SVP & General Counsel) Sale 4,066 55.90 227,269
2011-05-18 Boger Joshua S (Director) Sale 4,000 55.85 223,400
2011-05-18 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-05-17 Silva Paul M (VP & Corp Controller) Sale 701 57.01 39,964
2011-05-17 Kelly Lisa (SVP, Human Resources) Sale 663 57.00 37,791
2011-05-17 Smith Ian F (EVP & CFO) Sale 709 56.95 40,377
2011-05-16 Mueller Peter (EVP, Global R&D, CSO) Sale 2,500 56.48 141,200
2011-05-16 Mueller Peter (EVP, Global R&D, CSO) Option Ex 2,500 10.41 26,025
2011-05-11 Boger Joshua S (Director) Sale 4,000 55.97 223,860
2011-05-11 Boger Joshua S (Director) Option Ex 4,000 24.66 98,640
2011-05-09 Kelly Lisa (SVP, Human Resources) Sale 1,906 56.65 107,969
2011-05-09 Kelly Lisa (SVP, Human Resources) Option Ex 1,906 18.93 36,080
2011-05-02 Boger Kenneth S (SVP & General Counsel) Sale 5,000 55.79 278,950

Insider trading activities including stock purchases, stock sales, and option exercises of VRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vertex Pharmaceuticals Inc / Ma (symbol VRTX, CIK number 875320) see the Securities and Exchange Commission (SEC) website.